These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 34413281)

  • 1. Cardiac Amyloidosis Presenting with Pre-Excitation Syndrome, Heart Failure, and Severe Factor X Deficiency as Part of Systemic Amyloid Light-Chain (AL) Amyloidosis - A Fatal Combination.
    Almasri H; Almeer A; Awouda S; Hamid O; Sardar S; Anwer Z; Ibrahim F; Soliman D; Kandathil Y; Abu-Tineh M; Alabdul Razzak I; Alazawi SH
    Am J Case Rep; 2021 Aug; 22():e933398. PubMed ID: 34413281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.
    Harrison JS; Frazier SR; McConnell DD; Yasar SJ; Melnyk N; Salaru G
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):342-347. PubMed ID: 27676646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
    Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
    Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy.
    Chitimus DM; Berling E; Garderet L; Venturelli N; Malfatti E; Authier FJ; Nicolas G; Laforêt P; Lefeuvre C
    Eur J Neurol; 2023 Mar; 30(3):745-748. PubMed ID: 36403110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
    Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
    Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
    Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
    Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
    Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
    Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent Acute Heart Failure and Renal Failure in Amyloid Light Chain Amyloidosis.
    Cass K; Luna L; Kivlin W; Fechter B; Paudel H
    WMJ; 2024 Jul; 123(3):225-228. PubMed ID: 39024153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with AL amyloidosis with negative free light chain results.
    Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
    Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
    Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
    Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Electrocardiographic Follow-Up of a Patient with Light-Chain Cardiac Amyloidosis.
    Ohara T; Murata H; Yodogawa K; Yasutake M
    J Nippon Med Sch; 2022 Mar; 89(1):119-125. PubMed ID: 33692307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Light chain amyloidosis].
    Hegenbart U; Aus dem Siepen F; Schönland S
    Inn Med (Heidelb); 2023 Sep; 64(9):842-847. PubMed ID: 37540260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daratumumab, pomalidomide, and dexamethasone as a bridging therapy to autologous stem cell transplantation in a case of systemic light-chain amyloidosis with advanced cardiac involvement.
    Arnall JR; Usmani SZ; Adamu H; Mishkin J; Bhutani M
    J Oncol Pharm Pract; 2019 Jun; 25(4):1021-1025. PubMed ID: 30477388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroduodenal Involvement in AL Amyloidosis: Case Report and Literature Review.
    Ramachandran R; Grantham T; Isaac-Coss G; Etienne D; Reddy M
    J Investig Med High Impact Case Rep; 2024; 12():23247096241237759. PubMed ID: 38462925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.
    Ma Y; Kwon EH; Lee JE; Kim K; Kim HJ; Kim SH
    Korean J Lab Med; 2011 Jul; 31(3):154-6. PubMed ID: 21779187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart transplantation and the subsequent treatment of AL amyloidosis].
    Adam Z; Krejčí J; Krejčí M; Němec P; Spinarová L; Zampachová V; Cermáková Z; Pika T; Pour L; Kořístek Z; Tomíška M; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2013 Feb; 59(2):136-47. PubMed ID: 23461404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic light-chain amyloidosis incidentally diagnosed after subtotal parathyroidectomy and thyroid lobectomy.
    Tsai K; Yu AC; Livhits MJ; Sajed D; Leung AM; Cheung DS
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33875506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of Systemic Light Chain Amyloidosis with Liver Involvement using Low-Frequency Daratumumab: A Case Report.
    Meng X; He J; Cheng F; Yan H; Zhu C; Guo X; Li Y; Cai Z; He D
    Am J Case Rep; 2024 Jan; 25():e942534. PubMed ID: 38229422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of daratumumab in refractory AL amyloidosis in a 96-year-old patient].
    Vial G; Lafargue A; Mercié P; Duffau P; Ribeiro E
    Rev Med Interne; 2022 Nov; 43(11):673-676. PubMed ID: 35934598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.